Search

everythinglearnresearchcommunity

for

Search:↓

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

New techniques improve hair restoration success.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Finasteride may worsen blood sugar control in diabetic patients.

Women with PCOS have lower zinc levels.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

PCOS is linked to hormone disorders and issues like infertility and irregular periods.

Biotin supplements significantly improve hair loss in people with telegon effluvium who lack biotin.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Changes in SHBG levels don't predict diabetes risk reduction.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Higher cholesterol levels increase aggressive prostate cancer risk.

Hair analysis showed very high metformin levels in two fatal overdose cases, suggesting it's useful in forensics but sweat may affect results.

Lower ghrelin levels and certain gene variations may increase acne risk.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Lower SHBG levels may increase the risk of PCOS.

High kallistatin levels in diabetics worsen wound healing by blocking important cell signals.

People with Parkinson's disease have higher levels of cortisone in their hair, which may indicate chronic stress hormone dysfunction.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Maintaining natural oxygen levels is crucial for healthy skin cells and effective treatments.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Women with PCOS have higher levels of thyroid autoantibodies.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Blood metabolites significantly influence alopecia areata risk.

Higher levels of DHEA and TNF-α are linked to PCOS symptoms.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.